Topic starter
24/10/2026 8:53 pm
TL;DR: The EU AI Act can apply to U.S. organisations when AI systems or GPAI models are placed on the EU market, put into service in the EU, or used outside Europe when outputs are used inside it, according to Saviynt. Visibility into where AI is used, where outputs go, and which role the organisation plays is now the gating control for compliance scoping.
Editorial analysis by NHI Mgmt Group, based on content published by Saviynt: “EU AI Act 101: Does the EU AI Act Apply to U.S. Companies?”.
Key questions
Q: How should security teams assess whether the EU AI Act applies to U.S. organisations?
A: Start with where the AI system or GPAI model is placed, put into service, or used, then trace where its outputs are consumed.
Q: Why does AI role classification matter under the EU AI Act?
A: Because the Act assigns different obligations to providers, deployers, importers, distributors, product manufacturers, and authorised representatives.
Q: What breaks when AI inventories do not show where outputs are used?
A: You lose the ability to determine whether a system falls within the Act’s scope or which obligations follow.
Practitioner guidance
- Build a cross-border AI inventory Track every AI system and GPAI model your organisation develops, deploys, imports, distributes, or uses, including where outputs are consumed.
- Classify each system by role Assign provider, deployer, importer, distributor, product manufacturer, or authorised representative status at the system level, not the company level.
- Map output destinations before legal review Document where model outputs are used, who acts on them, and whether any decisions or services reach the EU market.
Bottom line: The core risk is not just whether an organisation uses AI, but whether that AI creates EU AI Act exposure through market access, service delivery, or downstream use of outputs.
Explore further
View Full Forum → | NHI Foundation Course → | Our Services → | Read the full analysis →